Beauty & Skincare Trends (2025): What to Watch Out For
The actress and newlywed raves about ADVAlight, Belo’s all-in-one skin laser.
Caring for your skin surely looks different in 2023 than it did years ago. Before, skincare limited people to topical products and lengthy routines. These typically address only one or two skin concerns at a time.
Today, technology is on our side, allowing us to address multiple skin problems in just one treatment. In line with the commitment to pursue global advancements, Belo introduced ADVAlight in 2021, the world’s sole solid-state yellow laser. This technology efficiently addresses various skin concerns simultaneously. Given the challenge of healing skin and the busy lives of many, ADVAlight offers a time-saving solution. This is a quick and painless 20-minute procedure, capable of producing results from just one session.
The benefits are endless. ADVAlight addresses concerns such as redness, hyperpigmentation, oiliness, acne, and large pores. Additionally, patients can also expect the immediate reduction of vascular lesions, melasma, acne scars, and wrinkles. That’s an all-in-one solution perfect for individuals who juggle multiple roles. After all, beauty treatments should allow people to enjoy their lives, not to take too much time off of it.
Serving as the face of ADVAlight is actress Lovi Poe-Blencowe. She credits ADVAlight in addressing skin concerns that affect her job as an on-screen talent. “Can you imagine—it’s actually part of my job [as an actress] to have clear skin, and yet there were still moments wherein I had a hard time [achieving the skin quality I needed to have]. Seeing the results from ADVAlight just made me want to keep going.”
While ADVAlight is already effective on its own, those who want to take it a step further may pair other Belo treatments with ADVAlight, to target their skin concerns better: ASCE+ Exosomes, Thermage, Angel Whitening, Botox, and the various facial treatments offered by Belo.
For consultation, call 8819-BELO or visit our website today.